Lilly’s decision to offer vials has also been seen as its way to combat the rise in compounding. Patients have been turning ...
AbbVie closed out the year on a high note, as its blockbuster biologic Skyrizi once again claimed the top spot in 2024’s ...
Fourth-quarter earnings at JPMorgan Chase, Wells Fargo, Goldman Sachs, and Citigroup beat analysts’ estimates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback